by Wendy Lim, Sara K. Vesely, and James N. George

Slides:

Advertisements

Similar presentations

Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes by Marie Scully, Mari Thomas, Mary Underwood,

Advertisements

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,

How I treat HHV8/KSHV-related diseases in posttransplant patients by Giovanni Riva, Mario Luppi, Patrizia Barozzi, Fabio Forghieri, and Leonardo Potenza.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Lenalidomide augments actin remodeling and lowers NK- cell activation thresholds by Kathryn Lagrue, Alex Carisey, David J. Morgan, Rajesh Chopra, and Daniel.

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura by Miguel Hie, Julie Gay, Lionel.

The influence of high-altitude living on body iron

The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of.

A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura by Johannes Matschke,

by Nadine Martel, James Lee, and Philip S. Wells

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma by Jonathan.

by Henrik Frederiksen, and Kai Schmidt

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

by Timothy P. Hughes, and David M. Ross

by James O. Armitage, and Dan L. Longo

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma by Nicolaus Kröger,

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.

Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis by Shameem Mahmood, Julie Blundell,

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura by Christoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, Friedrich.

Hepatitis C in the rituximab era

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Tax fingerprint in adult T-cell leukemia

How I treat elderly patients with myeloma

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim.

Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib by Preetesh Jain, Michael Keating, William Wierda, Zeev Estrov, Alessandra.

Topical Sodium Nitrite Is Effective In Reducing Leg Ulcer-Associated Pain In Patients With Sickle Cell Disease by Caterina P. Minniti, Caroline Cantilena,

Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to.

Pregnancy outcomes after maternal exposure to rituximab

Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children by Ayami Yoshimi, Charlotte.

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome by Kerry J.

Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura by Evaren E. Page, Johanna A. Kremer.

by Jessica A. Reese, Xiaoning Li, Manfred Hauben, Richard H

by Alexander Röth, Andreas Hüttmann, Russell P

by Sabah Sallah, and Jim Y. Wan

by Karl-Georg Fischer, Barbara Deschler, and Michael Lübbert

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response by Fotios P. Panitsas, Maria Theodoropoulou,

by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus

Stage C or not stage C…? by Claire Dearden Blood

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Blocking VWF platelet binding to treat TTP

by Michael F. Leahy, and J. Harvey Turner

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

by J. Evan Sadler Blood Volume 112(1):11-18 July 1, 2008

Volume 75, Pages S55-S58 (February 2009)

Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? by Marc Michel, Nichola Cooper, Christelle Jean, Christine Frissora, and.

How I treat catastrophic thrombotic syndromes

Anergy: the CLL cell limbo

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

Overall survival by SCT versus observation in first complete remission

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.

Plasma biomarker concentrations between study groups.

Increased Urinary Albumin Excretion Following Recovery From Thrombotic Thrombocytopenic Purpura Due to Acquired ADAMTS13 Deficiency Dustin J. Little,

by Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.

Rituximab immunotherapy: it’s getting personal

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to minimum observed white blood cell.

Thrombotic thrombocytopenic purpura

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment by Waleed Ghanima, Bertrand Godeau,

Optimizing therapy for nodal marginal zone lymphoma

Balancing bleeding in brain metastases

Thrombocytopenia in pregnancy

Cold agglutinin disease

Presentation transcript:

by Wendy Lim, Sara K. Vesely, and James N. George The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura by Wendy Lim, Sara K. Vesely, and James N. George Blood Volume 125(10):1526-1531 March 5, 2015 ©2015 by American Society of Hematology

Literature search data Literature search data. *One article included 2 case series: one case series of patients receiving initial treatment with rituximab and another case series of asymptomatic patients receiving rituximab prophylaxis. Literature search data. *One article included 2 case series: one case series of patients receiving initial treatment with rituximab and another case series of asymptomatic patients receiving rituximab prophylaxis. Wendy Lim et al. Blood 2015;125:1526-1531 ©2015 by American Society of Hematology

Rituximab for the treatment of patients with TTP and for treatment of ADAMTS13 deficiency during remission: studies with a comparison group. Rituximab for the treatment of patients with TTP and for treatment of ADAMTS13 deficiency during remission: studies with a comparison group Wendy Lim et al. Blood 2015;125:1526-1531 ©2015 by American Society of Hematology